Status:
COMPLETED
Effect of Lugol's Solution in the Patients With Graves' Disease
Lead Sponsor:
Istanbul University
Conditions:
Graves Disease
Eligibility:
All Genders
14-61 years
Brief Summary
Context: Although some of endocrine surgeons administer Lugol's solution to decrease thyroid gland vascularity, there is still no agreement on its effectiveness. Objective: The aims of this clinical ...
Detailed Description
Thirty-six patients were randomly assigned to preoperative medication with Lugol's solution. Patients in group 1 (n=17) received Lugol's solution for 10 days before surgical intervention, whereas pati...
Eligibility Criteria
Inclusion
- Graves disease
Exclusion
- Anticoagulant usage,
- Previous thyroid operation,
- Refused to participate in this study.
Key Trial Info
Start Date :
September 1 2005
Trial Type :
OBSERVATIONAL
End Date :
September 1 2006
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00432146
Start Date
September 1 2005
End Date
September 1 2006
Last Update
October 20 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.